Interim report January - June 2016 SUCCESSFUL SHARE ISSUE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Interim report January - June 2016

SUCCESSFUL SHARE ISSUE AND CONTINUED STREAMLINING QUARTER APRIL-JUNE 2016 • Rental income amounted to MSEK 642 (615) • Profit from property management totaled MSEK 352 (346), corresponding to SEK 2.23 per ordinary share (2.36) • Profit after tax amounted to MSEK 703 (670), corresponding to SEK 4.62 per ordinary share (4.62) • Cash flow from operating activities was MSEK 121 (153), corresponding to SEK 0.64 per ordinary share (0.94) INTERIM PERIOD JANUARY - JUNE 2016 • Rental income amounted to MSEK 1,292 (1,203) • Profit from property management totaled MSEK 693 (613), corresponding to SEK 4.61 per ordinary share (4.13) • Profit after tax amounted to MSEK 1,357 (1,177), corresponding to SEK 9.37 per ordinary share (8.21) • Recognized property value of SEK 31.9 billion (27.8) pertains to 417 (366) directly owned properties • Net asset value (EPRA NAV) per ordinary share was SEK 81.58 (65.43) • Cash flow from operating activities was MSEK 414 (537), corresponding to SEK 2.60 per ordinary share (3.57) SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER • In July, Joacim Sjöberg was appointed deputy CEO, taking office in October 2016. At the same time, CEO Jens Engwall announced that he planned to step down from his operational position prior to the end of 2017. • A successful new share issue, with preferential rights for holders of ordinary Hemfosa shares, contributed approximately SEK 1.8 billion to the company. • Hemfosa’s 2016 Annual General Meeting (AGM) was held on April 19. Motions adopted by the AGM included payment of a dividend of SEK 4.20 per ordinary share and of SEK 10.00 per preference share both to be paid quarterly. • Hemfosa acquired 13 school properties properties at an underlying property value of approximately MSEK 444. During the quarter, possession was taken of ten of the properties. • Söderport Fastigheter, a joint venture in which Hemfosa owns 50 percent, divested a property at an underlying property value of MSEK 170. • Hemfosa acquired a healthcare property in the Stockholm area at an underlying property value of MSEK 195. • Hemfosa took over an office property in the municipality of Fredrikstad Norway at an underlying property value of MSEK 84. COMMENTS FROM THE CEO During the second quarter, Hemfosa implemented a rights issue of ordinary shares that contributed just over SEK 1.8 billion to the company. Thanks to the rights issue, we can take swifter action when we identify the right acquisition targets and continue to grow our community service properties. To strengthen Hemfosa’s management and ensure that the company’s long-term strategy is implemented forcefully, we have employed Joacim Sjöberg as deputy CEO. By focusing on community service properties, we are building a property portfolio hallmarked by stable cash flows and long-term tenants. The major acceptance of the rights issue among our shareholders was highly encouraging and strengthens us in our conviction that we are thinking correctly and doing the right things – and we now have a better platform for continuing to grow Hemfosa in our three markets in the Nordic region. We are doing this with the distinct objective of streamlining the portfolio so that community service properties will account for at least 75 percent of the property value; today, they represent 63 percent. STRONGER PLATFORM IN THE NORDIC REGION During the quarter, we implemented a number of favorable transactions and strengthened our profit from property management. In Sweden, we acquired 13 school properties, primarily in the Stockholm region, at a value of MSEK 444, with an exclusive option to sign an agreement in the third quarter of 2016 to acquire an additional two schools. These are properties in good locations that are fully leased to well-established school operators, and we are delighted to be able to complement our portfolio with them. In June, we also signed an agreement for the acquisition of a centrally located healthcare property in Vällingby, western Stockholm, at a value of MSEK 195, with possession to be taken in September. In the Norwegian market during the quarter, we acquired a 20 -percent stake in a property company focused on community service properties, while also taking possession of the Ringstabekk senior citizens center in the municipality of Bærum in the Oslo region. We are continuing our determined and active efforts to build Hemfosa’s position as the specialist in community service properties. It is gratifying that, despite intensifying competition not least in Sweden, we are maintaining a high transaction tempo and completing acquisitions on favorable terms – which was the precondition we set when implementing the rights issue during the spring. A key prerequisite for this is the expertise, determination and market familiarity possessed by Hemfosa’s organization. SAFEGUARDING COMPETENCIES AND SUCCESSION PLANNING In Norway, we have continued to strengthen the organization through the appointment of an experienced head of property operations, who will focus on developing our property management, thus providing management in Norway with better prerequisites to identify and implement attractive acquisitions and projects. In Norway, we are now established with the strength we need to manage a growing portfolio and, in Finland, we are working to get an optimal organization in place. I am delighted that Joacim Sjöberg will be strengthening Group Management as Deputy CEO starting this autumn, and will thus ensure the continued building of Hemfosa Fastigheter. Joacim Sjöberg has been close to the company as a financial adviser for many years; he possesses solid strategic expertise and is highly familiar with Hemfosa’s corporate culture. With him in the organization, we can continue our efforts to achieve our objectives and I can start to plan an orderly succession and eventually focus on playing a freer role as a major shareholder and ideally as a Board member. Meanwhile, we will devote our full force to continuing to implement value -creating business and developing the existing operations in our markets in the Nordic region. Jens Engwall, CEO For further information, please contact: Jens Engwall, CEO, jens.engwall@hemfosa.se, mobile +46 70 690 65 50 Karin Osslind, CFO, karin.osslind@hemfosa.se, mobile +46 70 794 93 37

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading